Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide).

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Vaccine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0264-410X(93)90012-MPMID 8094929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diarrheal disease during Operation Desert Shield.

  1991cited by this paper
• Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

  1991cited by this paper
• Microparticles as potentially orally active immunological adjuvants.

  1989cited by this paper
• Biodegradable microspheres: vaccine delivery system for oral immunization.

  1989cited by this paper
• Purification and analysis of colonization factor antigen I, coli surface antigen 1, and coli surface antigen 3 fimbriae from enterotoxigenic Escherichia coli

  1989cited by this paper
• Mucosal and systemic immune responses in BALB/c mice to Bacteroides gingivalis fimbriae administered orally

  1989cited by this paper
• Immune responses to influenza virus in orally and systemically immunized mice.

  1989cited by this paper
• PREPARATION OF INFANT FORMULA

  1988cited by this paper
• Oral immunization of rabbits with enterotoxigenic Escherichia coli protects against intraintestinal challenge

  1988cited by this paper
• Progress towards a vaccine against enterotoxigenic Escherichia coli.

  1988cited by this paper
• Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006.

  1988cited by this paper
• Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans

  1984cited by this paper
• Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive.

  1983cited by this paper
• Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens.

  1982cited by this paper
• Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios.

  1977cited by this paper
• Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress.

  1976cited by this paper

• Synthesis of Gemcitabine-Loaded PLGA Microparticles with Green Solvents

  2025cites this paper
• PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases

  2023cites this paper
• Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren’s syndrome-like disease

  2023cites this paper
• Molecular mechanism of Escherichia coli H10407 induced diarrhoea and its control through immunomodulatory action of bioactives from Simarouba amara (Aubl.)

  2021cites this paper
• Polymeric Nanoparticle Based Diagnosis and Nanomedicine for Treatment and Development of Vaccines for Cerebral Malaria: A Review on Recent Advancement.

  2021cites this paper
• A Review on Poly-Lactic-Co-Glycolic Acid as a Unique Carrier for Controlled and Targeted Delivery Drugs

  2021cites this paper
• Potential application of PLGA microsphere for tissue engineering

  2021cites this paper
• Development of PLGA/Gemcitabine carriers using solvents and high pressure CO2

  2020cites this paper
• Plant‐derived protein bodies as delivery vehicles for recombinant proteins into mammalian cells

  2020cites this paper
• Biotechnology and Bioengineering: Volume 117, Number 10, October 2020

  2020cites this paper
• Biomedical applications of PLGA particles

  2019cites this paper
• Vaccines the tugboat for prevention-based animal production

  2019cites this paper
• Sustained drug delivery of capecitabine using natural bee wax and synthetic polymer plga

  2018cites this paper
• Optimization of PLGA formulation containing protein or peptide-based antigen: Recent advances.

  2018cites this paper
• Recent advancement in nanocarriers for oral vaccination

  2018cites this paper
• Liberación controlada de principios activos mediante el empleo de formulaciones galénicas

  2017cites this paper
• L-Selectin-Deficient Mice Orally Immunized Impaired Mucosal Immunity in

  2017cites this paper
• PLA and PLGA nanoarchitectonics for improving anti-infective drugs efficiency

  2016cites this paper
• Formulation of depot delivery systems

  2016cites this paper
• Formulation development of small and large volume injections

  2016cites this paper
• Single-injection vaccines: Progress, challenges, and opportunities.

  2015cites this paper
• PLGA: a unique polymer for drug delivery.

  2015cites this paper
• Physicomechanical properties of sintered scaffolds formed from porous and protein-loaded poly(DL-lactic-co-glycolic acid) microspheres for potential use in bone tissue engineering

  2015cites this paper
• Regulatory T-cell vaccination independent of auto-antigen

  2014cites this paper
• Microencapsulation of mPEG-Modified Lysozyme in PLGA by Spray Drying Master Thesis

  2014cites this paper
• Microfluidic approach to preparing polymer microspheres for enhanced oral protein drug delivery

  2013cites this paper
• IDENTIFICATION OF IMMUNODOMINANT T CELL EPITOPES FROM ENTEROTOXIGENIC E. coli COLONIZATION FACTOR ANTIGEN I (CFA/I) RESPONSIBLE FOR T HELPER CELL CYTOKINES

  2012cites this paper
• Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans

  2012cites this paper
• Serum Antibodies Protect against Intraperitoneal Challenge with Enterotoxigenic Escherichia coli

  2011cites this paper
• Poly Lactic-co-Glycolic Acid ( PLGA ) as Biodegradable Controlled Drug Delivery Carrier

  2011cites this paper
• Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

  2011cites this paper
• VACCINE PLATFORM FOR INFECTION OR AUTOIMMUNE DISEASES USING AN ETEC FIMBRIAL SCAFFOLD

  2009cites this paper
• Microparticles as tissue engineering scaffolds: Manufacture, modification and manipulation

  2008cites this paper
• Tolerance in the absence of autoantigen.

  2007cites this paper
• Serum antibody response induced in mice after oral administration of three different antigens of enterotoxigenic Escherichia coli in enteric coated microparticles.

  2006cites this paper
• Importance of Heat-Labile Enterotoxin in Colonization of the Adult Mouse Small Intestine by Human Enterotoxigenic Escherichia coli Strains

  2006cites this paper
• A Live Diarrheal Vaccine Imprints a Th2 Cell Bias and Acts as an Anti-Inflammatory Vaccine1

  2005influential citation
• Microparticles for oral delivery of vaccines

  2005influential citation
• Partially Assembled K99 Fimbriae Are Required for Protection

  2005cites this paper
• Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations.

  2005cites this paper
• VaccineBias and Acts as an Anti-Inflammatory A Live Diarrheal Vaccine Imprints a Th2 Cell

  2005influential citation
• Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice.

  2004cites this paper
• Pathogenicity and Immune Response Measured in Mice following Intranasal Challenge with Enterotoxigenic Escherichia coli Strains H10407 and B7A

  2003cites this paper
• Innate immunity and biodefence vaccines

  2003cites this paper
• Mucosal immunization of BALB/c mice using enterotoxigenic Escherichia coli colonization factors CFA/I and CS6 administered with and without a mutant heat-labile enterotoxin.

  2003cites this paper
• Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge.

  2002cites this paper
• Vaccine Vector Salmonella with a L-Selectin-Deficient Mice Orally Immunized Impaired Mucosal Immunity in Nancy

  2001cites this paper
• Impaired Mucosal Immunity in L-Selectin-Deficient Mice Orally Immunized with a Salmonella Vaccine Vector1

  2001cites this paper
• Intranasal vaccination of New Zealand white rabbits against pasteurellosis, using alginate-encapsulated Pasteurella multocida toxin and potassium thiocyanate extract.

  2000cites this paper
• Attenuated Shigella flexneri 2a Vaccine Strain CVD 1204 Expressing Colonization Factor Antigen I and Mutant Heat-Labile Enterotoxin of Enterotoxigenic Escherichia coli

  2000cites this paper
• coli Escherichia Enterotoxin of Enterotoxigenic Factor Antigen I and Mutant Heat-Labile Strain CVD 1204 Expressing Colonization 2 a Vaccine Shigella flexneri Attenuated

  2000cites this paper
• Microencapsulated enterotoxigenic Escherichia coli and detached fimbriae for peroral vaccination of pigs.

  2000cites this paper
• Attenuated Shigella flexneri 2a Vaccine Strain CVD 1204 Expressing Colonization Factor Antigen I and Mutant Heat-Labile Enterotoxin of Enterotoxigenic Escherichia coli

  2000cites this paper
• The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.

  2000cites this paper
• New approaches to antigen delivery.

  2000cites this paper
• Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination.

  2000cites this paper
• Expression of Recombinant EnterotoxigenicEscherichia coli Colonization Factor Antigen I bySalmonella typhimurium Elicits a Biphasic T Helper Cell Response

  1999cites this paper
• Immunization against the colonization factor antigen I of enterotoxigenic Escherichia coli by administration of a bivalent Salmonella typhimurium aroA strain.

  1998cites this paper
• Oral Immunization with a Salmonella typhimurium Vaccine Vector Expressing Recombinant Enterotoxigenic Escherichia coli K99 Fimbriae Elicits Elevated Antibody Titers for Protective Immunity

  1998cites this paper
• Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres.

  1998cites this paper
• The effect of physical barriers and properties on the oral absorption of particulates.

  1998cites this paper
• Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches.

  1998cites this paper
• Controlled drug delivery from a novel injectable in situ formed biodegradable PLGA microsphere system

  1998cites this paper
• Evaluation of the Antibody Response after Oral Immunization by Microparticles Containing an Antigen from Schistosoma Mansoni

  1998cites this paper
• Polymer‐grafted starch microparticles for oral and nasal immunization

  1998cites this paper
• Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.

  1998cites this paper
• What's going on in vaccine technology?

  1997cites this paper
• Oral immunization of rainbow trout with antigen microencapsulated in poly(DL-lactide-co-glycolide) microparticles.

  1997cites this paper
• Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres.

  1997cites this paper
• Oral delivery of microencapsulated proteins.

  1997cites this paper
• Drug delivery to the lymphatic system.

  1997cites this paper
• Immunoprophylactic intervention in chemical toxicity and carcinogenicity.

  1997cites this paper
• Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates

  1997cites this paper
• Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.

  1996cites this paper
• 12 – Poly(lactide-co-glycolide) Microencapsulation of Vaccines for Mucosal Immunization

  1996cites this paper
• Controlled delivery of antigens and adjuvants in vaccine development.

  1996cites this paper
• Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice

  1996cites this paper
• Oral administration of Escherichia coli in enteric coated microparticles induces serum antibodies against lipopolysaccharide antigens

  1996cites this paper
• Intestinal absorption of PLAGA microspheres in the rat.

  1996cites this paper
• Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by ΔaroC, ΔaroD Salmonella typhi vaccine strain CVD 908

  1995cites this paper
• Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriers.

  1995cites this paper
• Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.

  1995cites this paper
• A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide.

  1995cites this paper
• Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by delta aroC, delta aroD Salmonella typhi vaccine strain CVD 908.

  1995cites this paper
• Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres

  1995cites this paper
• Biodegradable microspheres in drug delivery.

  1995cites this paper
• Polymer microspheres for vaccine delivery.

  1995cites this paper
• The importance of gastrointestinal uptake of particles in the design of oral delivery systems

  1995cites this paper
• Potential of polymer microencapsulation technology for vaccine innovation.

  1994cites this paper
• Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique

  1994cites this paper
• Enhancement of rotavirus immunogenicity by microencapsulation.

  1994cites this paper
• Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres.

  1994cites this paper
• Targeting of drugs and vaccines to the gut.

  1994cites this paper
• Optimizing gastrointestinal delivery of drugs.

  1994cites this paper
• Vaccine Delivery Systems: Potential Methods for Use in Antifertility Vaccines

  1993cites this paper
• Chapter 10 Oral Delivery of Microencapsulated Proteins

  year unknowncites this paper